Pfizer/BioNTech Announce Positive Comirnaty Results Amid Regulatory Limbo

States Push Back Against Access Restrictions

 
• By Alaric DeArment
  
Comirnaty
BioNTech and Pfizer's COVID-19 vaccine Comirnaty has transformed the company's fortunes - and the image of the whole German biotech sector. Credit: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip